Azmi Nabulsi - Jul 15, 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
Chief Operating Officer
Signature
/s/ Molly Henderson, Attorney-in-Fact for Azmi Nabulsi
Stock symbol
PHAT
Transactions as of
Jul 15, 2024
Transactions value $
-$127,760
Form type
4
Date filed
7/17/2024, 02:52 PM
Previous filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHAT Common Stock Sale -$128K -10.9K -4.34% $11.72 240K Jul 15, 2024 Direct F1, F2
holding PHAT Common Stock 3.58K Jul 15, 2024 By 401(k)
holding PHAT Common Stock 786K Jul 15, 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
F2 Includes 1,754 shares acquired in January 2024 and 1 share acquired in July 2024 under the Phathom Pharmaceuticals, Inc. employee stock purchase plan